Genie Asset Management
16F, Anchor1 15, 39, Gukjegeumyung-ro, Yeongdeungpo-gu, Seoul, Seoul-t'ukpyolsi, 07335, South Korea
Overview
Genie Asset Management is a private equity firm that strives for selection, focus, and stable profits. Genie Asset Management was founded in 2019 and was headquartered in Seoul, South Korea.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Asset Management
- Consulting
- Financial Services
- Risk Management
Investment portfolio
- ILIAS Biologics
Participated · Series B · Oct 2020
Ilias Biologics develops exosome-based therapeutics using its EXPLOR® platform, a novel protein-loading method that enables free-form loading of large therapeutic proteins into exosome lumens. The company’s lead candidate, ILB-202, produced promising preclinical data published in Science Advances, and Ilias secured a key exosome engineering patent from the USPTO in July. The Series B proceeds will support continued development of the EXPLOR platform and advancement of its exosome therapeutics pipeline across inflammatory diseases and oncology. Ilias plans to submit an IND to the U.S. FDA and initiate a first-in-human clinical trial by the second half of 2021 targeting an undisclosed acute inflammatory disease, and is in active discussions with multiple pharmaceutical companies for potential collaborations. Financially, the company has raised a total of $40.2M since its foundation in November 2015. Management is led by CEO Dr. Chulhee Choi and is planning an IPO on KOSDAQ in Q1 2022, with underwriter contracts being finalized.
Team
No current team members are available.